Stock Events

Stock Events

SAB Biotherapeutics (SABS) Q2 2024 Earnings

20MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.96

-0.66

-0.36

-0.06

Details

Expected EPS

-0.96

Actual EPS

-0.54

Surprise EPS

0.42

Surprise Percent

+43.75%

Description

SAB Biotherapeutics (SABS) has reported earnings of -0.54 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.